Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)

Individuals with metabolic dysfunction–associated fatty liver disease (MAFLD) have elevated plasma lipids as well as glucagon, although glucagon suppresses hepatic VLDL-triglyceride (TG) secretion. We hypothesize that the sensitivity to glucagon in hepatic lipid metabolism is impaired in MAFLD. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Heebøll, Sara, Risikesan, Jeyanthini, Ringgaard, Steffen, Kumarathas, Indumathi, Sandahl, Thomas D., Grønbæk, Henning, Søndergaard, Esben, Nielsen, Søren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630084/
https://www.ncbi.nlm.nih.gov/pubmed/36001750
http://dx.doi.org/10.2337/db22-0313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630084/
https://www.ncbi.nlm.nih.gov/pubmed/36001750
http://dx.doi.org/10.2337/db22-0313

Ejemplares similares